BPS BPS-Pharmacotherapy : Pharmacotherapy (Part1 and Part2) Exam

Our braindumps (BPS-Pharmacotherapy - Pharmacotherapy (Part1 and Part2) Exam) are very good:

As for our braindumps we provide you three types to choose. The BPS-Pharmacotherapy PDF type is available for reading and printing. You can print more and practice many times. Also you can share with your friends and compete with them. The BPS-Pharmacotherapy Software type can be downloaded in all electronics and is more inactive and interesting when you are learning. Also the software has memory function that it can pick out mistakes you make and it will require you practice many times. The BPS-Pharmacotherapy On-Line type is the updated one based on soft type. Except of the advantages on soft type it has more functions and it makes you study while you are playing.

Our company BraindumpStudy is powerful:

BraindumpStudy was built by several elite managers from different international IT companies since 2009. These people want to help more ambitious men achieve their elite dream. Our managers can get exam news always from their old friends who are working at kinds of internal company. So BPS-Pharmacotherapy is latest and valid. Our IT management will update every day.

Our service is the best:

1: As we mentioned we guarantee BPS-Pharmacotherapy 100% pass. Once you fail the exam you send us the unqualified score scanned and we will full refund you. No help, No pay!
2: Our service time is 7*24 hours. If you have any problem about BPS-Pharmacotherapy please email to us we will reply you in two hours.
3: Some people are afraid that their privacy will be unsafe and buying BPS-Pharmacotherapy study guide is known by others. About security we are very careful and build an official process to handle your information. It is very safe.
4: For our regular BPS-Pharmacotherapy customer we will give discount if you want to buy other study guide. Also we will send you holidays coupon if you want. Other service details please ask us.

Don't hesitate again. We have good products and service. Passing BPS-Pharmacotherapy is a piece of cake with our study guide. Don't waste your time. Come on! Success is waiting for you!

Instant Download: Upon successful payment, Our systems will automatically send the product you have purchased to your mailbox by email. (If not received within 12 hours, please contact us. Note: don't forget to check your spam.)

If you have problem on this exam BPS-Pharmacotherapy choosing us may be your best choice. Our pass rate is high to 98.9% and the similarity percentage between our BPS-Pharmacotherapy study guide and real exam is 90% based on our seven-year educating experience.

BPS BPS-Pharmacotherapy Exam Syllabus Topics:

BPS Pharmacotherapy (Part1 and Part2) Sample Questions:

Question #1
Which of the following components of a grant proposal defines the study hypothesis?

A. Research design
B. Significance
C. Specific aims
D. Background

Question #2
A study shows that the participants who received 6 months of a new oral anticoagulant after a venous thromboembolism were randomized to continue with the new oral anticoagulant (n =
612) or to placebo (n = 611) for 18 months. Thromboembolism recurred in 12 subjects in the new oral anticoagulant group and 71 subjects in the placebo group (hazard ratio 0.17; 95% CI, 0.09-
0.30; p < 0.001).
Which of the following statements regarding these results is correct?

A. The new oral anticoagulant reduces the relative risk of a secondary venous thromboembolism by 17% compared to placebo.
B. The difference between the new oral anticoagulant and placebo in the secondary prevention of venous thromboembolism is not statistically significant.
C. The new oral anticoagulant reduces the relative risk of a secondary venous thromboembolism by 83% compared to placebo.
D. The new oral anticoagulant reduces the relative risk of a secondary venous thromboembolism by 9.6% compared to placebo.

Question #3
A pharmacotherapy specialist is the anticoagulation clinic manager at a for-profit institution.
One of the internal medicine physicians in this institution is interested in submitting a research grant application to the National Institutes of Health (NIH) to study the effectiveness of low- intensity warfarin therapy on prevention of recurrent venous thromboembolism in patients.
This was the subject of the PREVENT trial.
With regard to the grant application, the pharmacotherapy specialist should inform the physician about which of the following restrictions?

A. NIH-funded research can take place only on the campus.
B. The NIH funds only novel research.
C. The NIH funds only studies involving drugs that have not yet been FDA-approved.
D. The NIH provides grants only to nonprofit organizations.

Question #4
Prednisone 10 mg orally daily is prescribed for a 68-year-old 60-kg patient with acute temporal arteritis. The pharmacotherapy specialist would recommend which of the following?

A. Dose should be increased to 20 mg daily.
B. Prednisone should be discontinued after 2 Weeks.
C. Dose should be increased to 60 mg daily.
D. Dose should be decreased to 5 mg daily.

Question #5
The risk of methemoglobinemia is highest with the use of:

A. benzocaine 10% oral gel in a 67-year-old for oral pain associated with ill-fitting dentures.
B. benzocaine 6% topical cream in a 25-year-old for pain associated with a sunburn.
C. benzocaine 7.5% oral gel in an 18-month-old for oral pain associated with teething.
D. benzocaine 20% topical cream in a 42-year-old for pain associated with insect bites.

Solutions: